Metreleptin and Lipodystrophy Data Presented at the International Meeting of Pediatric Endocrinology
15. September 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical Endocrinology
05. Mai 2017 09:00 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new...